(Total Views: 315)
Posted On: 08/02/2021 11:35:00 AM
Post# of 36542
You know, I understand the argument about how much it cost to put out a PR and that Generex needs to justify the cost to put out a PR, etc..
But, the issue here is that there were expectations to be met in July that were not. It is that simple. Multiple expectations were simply not met actually over several months.
That being said, at the very least, either a PR or better yet, a CC needs to be done to explain what is going on instead of leaving everyone in the dark. This is just bad faith by management towards faithful shareholders who have literally invested millions with this company overall.
We need to know what is going on with the IND.
We need to know what is going on with the IPO.
We need to know what is going on with Excellegan.
We need to know what is going on with Arizona, Florida, Ohio and the other deals they mentioned associated with those.
We need to know what is going on with the diabetes platform.
We need to know what is going on with the China deal.
We need to know if any revenue is being generated at all.
We as shareholders have a legiimate right to know all of these things and not be kept in the dark for months.
It's really that simple.
So, we at the very least need a CC that covers all of this.
But, the issue here is that there were expectations to be met in July that were not. It is that simple. Multiple expectations were simply not met actually over several months.
That being said, at the very least, either a PR or better yet, a CC needs to be done to explain what is going on instead of leaving everyone in the dark. This is just bad faith by management towards faithful shareholders who have literally invested millions with this company overall.
We need to know what is going on with the IND.
We need to know what is going on with the IPO.
We need to know what is going on with Excellegan.
We need to know what is going on with Arizona, Florida, Ohio and the other deals they mentioned associated with those.
We need to know what is going on with the diabetes platform.
We need to know what is going on with the China deal.
We need to know if any revenue is being generated at all.
We as shareholders have a legiimate right to know all of these things and not be kept in the dark for months.
It's really that simple.
So, we at the very least need a CC that covers all of this.
(4)
(0)
Scroll down for more posts ▼